NO20051987L - Behandling av soppinfeksjoner. - Google Patents

Behandling av soppinfeksjoner.

Info

Publication number
NO20051987L
NO20051987L NO20051987A NO20051987A NO20051987L NO 20051987 L NO20051987 L NO 20051987L NO 20051987 A NO20051987 A NO 20051987A NO 20051987 A NO20051987 A NO 20051987A NO 20051987 L NO20051987 L NO 20051987L
Authority
NO
Norway
Prior art keywords
treatment
posaconazole
fungal infections
medicament
prevention
Prior art date
Application number
NO20051987A
Other languages
English (en)
Norwegian (no)
Inventor
Rachel Courtney
Mark A Laughlin
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20051987L publication Critical patent/NO20051987L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20051987A 2002-09-23 2005-04-22 Behandling av soppinfeksjoner. NO20051987L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41298502P 2002-09-23 2002-09-23
PCT/US2003/029762 WO2004026303A2 (fr) 2002-09-23 2003-09-19 Traitement d'infections fongiques

Publications (1)

Publication Number Publication Date
NO20051987L true NO20051987L (no) 2005-04-22

Family

ID=32030948

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051987A NO20051987L (no) 2002-09-23 2005-04-22 Behandling av soppinfeksjoner.

Country Status (11)

Country Link
US (1) US20040058974A1 (fr)
EP (1) EP1542681A2 (fr)
JP (1) JP2006503839A (fr)
CN (1) CN1688306A (fr)
AU (1) AU2003282806A1 (fr)
BR (1) BR0314763A (fr)
CA (1) CA2499897A1 (fr)
MX (1) MXPA05003124A (fr)
NO (1) NO20051987L (fr)
WO (1) WO2004026303A2 (fr)
ZA (1) ZA200502374B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7406092B2 (en) * 2003-07-21 2008-07-29 Qlogic, Corporation Programmable pseudo virtual lanes for fibre channel systems
GB0409077D0 (en) * 2004-04-23 2004-05-26 Neutec Pharma Plc Treatment of fungal infections
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
US20060160823A1 (en) * 2004-05-28 2006-07-20 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
PL1776109T3 (pl) 2004-08-13 2009-06-30 Schering Plough Ltd Farmaceutyczna formulacja zawierająca antybiotyk, triazol i kortykosteroid
EP2343053A1 (fr) 2006-05-30 2011-07-13 Elan Pharma International Limited Compositions de posaconazole nanoparticulaire
EP2303026B1 (fr) 2008-06-17 2020-09-09 Brigham Young University Procédés de diagnostic, de détection, de tri et d'imagerie de stéroïdes cationiques antimicrobiens
ES2725784T3 (es) 2011-07-20 2019-09-27 Univ Brigham Young Compuestos de ceragenina hidrófobos y dispositivos que incorporan al mismo
US9694019B2 (en) 2011-09-13 2017-07-04 Brigham Young University Compositions and methods for treating bone diseases and broken bones
US9603859B2 (en) 2011-09-13 2017-03-28 Brigham Young University Methods and products for increasing the rate of healing of tissue wounds
WO2013109236A2 (fr) 2011-12-21 2013-07-25 Colgate-Palmolive Company Compositions de soin orales
US9533063B1 (en) 2012-03-01 2017-01-03 Brigham Young University Aerosols incorporating ceragenin compounds and methods of use thereof
EP3225113B1 (fr) 2012-05-02 2020-09-02 Brigham Young University Procédés de fabrication de matériaux particulaires de céragénine
CN102755628B (zh) * 2012-07-16 2013-10-23 中国科学院微生物研究所 一种抗真菌的药物组合物
WO2014062960A1 (fr) 2012-10-17 2014-04-24 Brigham Young University Traitement et prévention de la mastite
US9943529B2 (en) 2013-01-07 2018-04-17 Brigham Young University Methods for reducing cellular proliferation and treating certain diseases
RU2669800C2 (ru) 2013-03-15 2018-10-16 Брихэм Янг Юниверсити Способы лечения воспаления, аутоиммунных расстройств и боли
US11524015B2 (en) 2013-03-15 2022-12-13 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US10568893B2 (en) 2013-03-15 2020-02-25 Brigham Young University Methods for treating inflammation, autoimmune disorders and pain
US9387215B2 (en) 2013-04-22 2016-07-12 Brigham Young University Animal feed including cationic cholesterol additive and related methods
US11690855B2 (en) 2013-10-17 2023-07-04 Brigham Young University Methods for treating lung infections and inflammation
US20150203527A1 (en) 2014-01-23 2015-07-23 Brigham Young University Cationic steroidal antimicrobials
CA2844321C (fr) 2014-02-27 2021-03-16 Brigham Young University Composes antimicrobiens steroides cationiques
US9867836B2 (en) 2014-03-13 2018-01-16 Brigham Young University Lavage and/or infusion using CSA compounds for increasing fertility in a mammal
US10220045B2 (en) 2014-03-13 2019-03-05 Brigham Young University Compositions and methods for forming stabilized compositions with reduced CSA agglomeration
US9931350B2 (en) 2014-03-14 2018-04-03 Brigham Young University Anti-infective and osteogenic compositions and methods of use
US9686966B2 (en) 2014-04-30 2017-06-27 Brigham Young University Methods and apparatus for cleaning or disinfecting a water delivery system
US10238665B2 (en) 2014-06-26 2019-03-26 Brigham Young University Methods for treating fungal infections
US10441595B2 (en) * 2014-06-26 2019-10-15 Brigham Young University Methods for treating fungal infections
US10227376B2 (en) 2014-08-22 2019-03-12 Brigham Young University Radiolabeled cationic steroid antimicrobials and diagnostic methods
US10155788B2 (en) 2014-10-07 2018-12-18 Brigham Young University Cationic steroidal antimicrobial prodrug compositions and uses thereof
WO2016172543A1 (fr) 2015-04-22 2016-10-27 Savage Paul B Procédés pour la synthèse des céragénines
WO2016172553A1 (fr) 2015-04-22 2016-10-27 Savage Paul B Procédés de synthèse des céragénines
US9434759B1 (en) 2015-05-18 2016-09-06 Brigham Young University Cationic steroidal antimicrobial compounds and methods of manufacturing such compounds
US10226550B2 (en) 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
US10959433B2 (en) 2017-03-21 2021-03-30 Brigham Young University Use of cationic steroidal antimicrobials for sporicidal activity

Also Published As

Publication number Publication date
WO2004026303A3 (fr) 2004-04-29
JP2006503839A (ja) 2006-02-02
US20040058974A1 (en) 2004-03-25
ZA200502374B (en) 2006-12-27
WO2004026303A2 (fr) 2004-04-01
EP1542681A2 (fr) 2005-06-22
CN1688306A (zh) 2005-10-26
BR0314763A (pt) 2005-07-26
CA2499897A1 (fr) 2004-04-01
AU2003282806A1 (en) 2004-04-08
MXPA05003124A (es) 2005-06-22

Similar Documents

Publication Publication Date Title
NO20051987L (no) Behandling av soppinfeksjoner.
Nayak et al. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma
WO2021207409A3 (fr) Inhibiteurs à petites molécules de la replication virale du sars-cov-2 et leurs utilisations
AR043188A1 (es) Metodos y composiciones para el tratamiento de enfermedades y trastornos asociados con niveles elevados de citoquinas proinflamatorias
CY1116215T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
CR9842A (es) Composiciones de celecoxib
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
BRPI0515600A (pt) formas farmacêuticas opióides tendo cmédia e auc em estado estável proporcionais à dose e cmax de dose única inferior ao proporcional à dose
HUP0401998A2 (hu) PDE9 inhibitorok alkalmazása olyan gyógyszer előállítására, amellyel inzulin-rezisztencia szindróma és 2-es típusú diabétesz kezelhető
NO20056252L (no) Terapeutiske og profylaktiske metoder for neuromuskulaere lidelser
BR0109779A (pt) Soluções moleculares hidrofìlicas dispersas de carvedilol
MXPA05003366A (es) Inhibidores de la proteina reguladora de conductancia transmembranal de la fibrosis quistica y usos de los mismos.
NO20072931L (no) Forbedret doseringsregime av temozolomid for behandling av kreft basert pa pasientens MGMT-niva
NO20076245L (no) Anvendelse av TFPI for a behandle alvorlige bakterieinfeksjoner
BR0213292A (pt) tratamento de pneumonia severa por administração de inibidor da via de fator tecidual (tfpi)
Galabov et al. Combination activity of neuraminidase inhibitor oseltamivir and α-tocopherol in influenza virus A (H3N2) infection in mice
HUP9901360A2 (hu) Cimicifuga racemosa-ból származó extraktum alkalmazása
UY26422A1 (es) Método para administrar un inhibidor de fosfodiesterasa 4
PE11399A1 (es) Combinacion de loratadina y un descongestionante para el tratamiento del asma
BRPI0414305A (pt) sistema de liberação de drogas por via oral
ATE464052T1 (de) Neue pharmazeutische verwendungen von staurosporin-derivaten
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
PT1414467E (pt) Tratamento topico da mastalgia
NO20073575L (no) Farmasoytiske sammensetninger for behandling av cellulitt
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel